Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Assembly Biosciences (ASMB) Accumulated Depreciation & Amortization (2016 - 2023)

Assembly Biosciences has reported Accumulated Depreciation & Amortization over the past 10 years, most recently at $210000.0 for Q4 2023.

  • For Q4 2023, Accumulated Depreciation & Amortization fell 87.55% year-over-year to $210000.0; the TTM value through Dec 2023 reached $210000.0, down 87.55%, while the annual FY2023 figure was $210000.0, 87.55% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2023 was $210000.0 at Assembly Biosciences, down from $1.7 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $1.8 million in Q4 2020 and troughed at $135000.0 in Q1 2019.
  • A 5-year average of $1.1 million and a median of $1.2 million in 2019 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 854.81% in 2020 and later crashed 87.55% in 2023.
  • Year by year, Accumulated Depreciation & Amortization stood at $1.2 million in 2019, then skyrocketed by 53.0% to $1.8 million in 2020, then crashed by 34.26% to $1.2 million in 2021, then surged by 39.77% to $1.7 million in 2022, then crashed by 87.55% to $210000.0 in 2023.
  • Business Quant data shows Accumulated Depreciation & Amortization for ASMB at $210000.0 in Q4 2023, $1.7 million in Q4 2022, and $1.2 million in Q4 2021.